Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

Market open

/zigman2/quotes/210324360/composite

$

156.23

Change

-3.26 -2.04%

Volume

Volume 156,491

Nov 30, 2023, 12:30 p.m.

Real time quotes

/zigman2/quotes/210324360/composite

Previous close

$ 159.49

$ 156.23

Change

-3.26 -2.04%

Day low

Day high

$156.06

$161.00

Open
Open: 159.12

52 week low

52 week high

$110.45

$200.98

Open

Market cap

$8.90B

Average volume

669,891

P/E ratio

77.00

Rev. per Employee

$330,757

EPS

2.03

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  1. 10 Stocks Driving the Biotech Resurgence

    7:49 a.m. Aug. 18, 2022

    - Barron's Online

  2. Repligen stock price target raised to $275 from $213 at UBS

    7:54 a.m. Aug. 5, 2022

    - Tomi Kilgore

  3. Repligen started at buy with $213 stock price target at UBS

    8:20 a.m. July 20, 2022

    - Tomi Kilgore

  4. Repligen stock price target cut to $230 from $320 at Stifel Nicolaus

    8:01 a.m. Feb. 18, 2022

    - Tomi Kilgore

  5. Repligen stock price target raised to $335 from $255 at KeyBanc Capital

    5:15 a.m. Sept. 17, 2021

    - Tomi Kilgore

  6. How a 53-Year-Old Growth Fund Takes the Long View

    2:05 p.m. Nov. 29, 2021

    - Barron's Online

  7. Repligen started at overweight with $241 stock price target at KeyBanc Capital

    7:03 a.m. Nov. 10, 2020

    - Tomi Kilgore

  8. Small-Cap ‘Darlings’ Are Perking Up in 2020

    10:47 a.m. Jan. 21, 2020

    - Barron's Online

  9. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    6:28 a.m. July 13, 2019

    - Philip van Doorn

  10. Repligen started at overweight with $42 stock price target at J.P. Morgan

    7:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  11. Repligen stock fair value estimate raised to $47 from $42 at Janney

    10:26 a.m. June 23, 2017

    - Tomi Kilgore

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. 10-Q: REPLIGEN CORP

    3:44 p.m. May 2, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. 10-K: REPLIGEN CORP

    5:05 p.m. Feb. 22, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  3. Once Asking $120 Million, Los Angeles Estate Sells for $52 Million

    2:34 a.m. Feb. 24, 2023

    - The Wall Street Journal Interactive Edition

  4. Top 5 4th Quarter Trades of 12 West Capital Management LP

    2:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  5. Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?

    11:31 a.m. Dec. 2, 2022

    - Zacks.com

  6. BIIB or RGEN: Which Is the Better Value Stock Right Now?

    11:40 a.m. Nov. 23, 2022

    - Zacks.com

  7. Is Repligen a Value Trap or a Value Opportunity?

    11:42 a.m. Nov. 17, 2022

    - GuruFocus.com

  8. Frank Sands' Top 3rd-Quarter Trades

    4:44 p.m. Nov. 9, 2022

    - GuruFocus.com

  9. Frank Sands Buys 2, Sells 3 in 3rd Quarter

    12:00 p.m. Nov. 9, 2022

    - GuruFocus.com

  10. BIIB vs. RGEN: Which Stock Is the Better Value Option?

    11:40 a.m. Nov. 7, 2022

    - Zacks.com

  11. Repligen Corporation (RGEN) Q3 2022 Earnings Call Transcript

    12:17 p.m. Nov. 1, 2022

    - Seeking Alpha

  12. Repligen (RGEN) Q3 Earnings and Revenues Top Estimates

    7:45 a.m. Nov. 1, 2022

    - Zacks.com

  13. LGND vs. RGEN: Which Stock Is the Better Value Option?

    10:40 a.m. Oct. 21, 2022

    - Zacks.com

Rates »

Link to MarketWatch's Slice.